US approves Pharmaxis asthma test – Sydney Morning Herald

US approves Pharmaxis asthma test
Sydney Morning Herald
Pharmaxis Ltd, which develops treatments for respiratory and autoimmune diseases, has won regulatory approval to sell its asthma test kit, Aridol,
Pharmaxis (PXS) $2.40: Tim BorehamThe Australian

all 10 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *